Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma

INTRODUCTION: The aim of this study was to validate a molecular expression signature [cell cycle progression (CCP) score] that identifies patients with a higher risk of cancer-related death after surgical resection of early stage (I-II) lung adenocarcinoma in a large patient cohort and evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bueno, Raphael, Hughes, Elisha, Wagner, Susanne, Gutin, Alexander S., Lanchbury, Jerry S., Zheng, Yifan, Archer, Michael A., Gustafson, Corinne, Jones, Joshua T., Rushton, Kristen, Saam, Jennifer, Kim, Edward, Barberis, Massimo, Wistuba, Ignacio, Wenstrup, Richard J., Wallace, William A., Hartman, Anne-Renee, Harrison, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272230/
https://www.ncbi.nlm.nih.gov/pubmed/25396679
http://dx.doi.org/10.1097/JTO.0000000000000365

Ejemplares similares

Ejemplares similares